Krupin T, Webb G W, Barbosa A T, Gulli B, Levine J, Becker B
Invest Ophthalmol Vis Sci. 1984 Aug;25(8):932-7.
Administration of either thyrotropin-releasing hormone (TRH) or arginine vasopressin (a-VP) into the rabbit third ventricle elevated intraocular pressure (IOP). IOP was increased 3.6 mmHg 45 min after TRH (10 ng/0.1 ml) administration and increased 6.4 mmHg 45 min following delivery of a-VP (5 micrograms/0.1 ml). Outflow facility and episcleral venous pressure were not altered by either agent. Estimated aqueous humor flow 45 min after third ventricle administration was increased 66% after TRH and 91% after a-VP delivery. Posterior chamber aqueous humor ascorbate was reduced 60 min after TRH administration. Pretreatment with either systemic or topical atropine prevented the TRH or a-VP induced increase in IOP. Body temperature (BT), which was unaltered after TRH administration, was elevated by third ventricle delivery of a-VP. The a-VP induced increase in BT was blocked by systemic pretreatment with either indomethacin or atropine.
向兔第三脑室内注射促甲状腺激素释放激素(TRH)或精氨酸加压素(a-VP)均可升高眼压(IOP)。注射TRH(10 ng/0.1 ml)后45分钟眼压升高3.6 mmHg,注射a-VP(5微克/0.1 ml)后45分钟眼压升高6.4 mmHg。两种药物均未改变房水流畅系数和巩膜静脉压。第三脑室内给药后45分钟,估计房水流量在注射TRH后增加66%,在注射a-VP后增加91%。注射TRH后60分钟,后房房水的抗坏血酸盐减少。全身或局部使用阿托品预处理可防止TRH或a-VP诱导的眼压升高。注射TRH后体温(BT)未改变,而第三脑室内注射a-VP可使体温升高。全身用吲哚美辛或阿托品预处理可阻断a-VP诱导的体温升高。